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Covalent coupling of bovine rhodopsin to CPG-thiol glass was used for separation of CNBr peptides. It is shown that 
cysteine residues 322 and 323 in the C-terminal cytoplasmic fragment of rhodopsin are modified with palmitic acid. 
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1. INTRODUCTION 2. EXPERIMENTAL PROCEDURES 
Since the pioneering paper of Folch and Lees on 
the discovery of proteolipid [ 11, a series of covalent 
protein-lipid complexes extending from viral mem- 
brane glycoproteins [2] to proteins with the 
tumorogenic transformation activity [3] and a 
number of cellular proteins as diverse as ankyrin (a 
peripheral red cell membrane protein) [4], receptor 
of transferrin [5], calcium binding subunit of 
calcineurin [6] have been reported (review [7]). 
Bovine rhodopsin is one of the best character- 
ized membrane proteins. Its amino acid sequence is 
known both from protein and DNA sequencing 
[8,9]. Along with the most common post- 
translational glycosylation, rhodopsin has been 
shown to be modified by fatty acids [lo-121. 
In this paper, we show that Cys-322 and -323 in 
the C-terminal cytoplasmic fragment of bovine 
rhodopsin are palmitylated. 
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2.1. Materials 
The carrier used was porous CPG-thiol glass (Pierce, USA), 
bead size 125-177 firn and pore diameter 500 A. Chemicals 
specifically purchased were 2,2’-dipyridyl disulfide (Aldrich, 
USA), SDS (Serva, FRG), fl-mercaptoethanol and DTT (Sigma, 
USA). For HPLC separation, Nucleosil CS and Cts (particle 
diameter 7.5 pm) were obtained from Macherey-Nagel (FRG). 
Palmitic acid and a standard mixture of fatty acids were from 
Sigma (USA). All other reagents were of analytical grade. 
2.2. Methodr 
Activation of the carrier and determination of its capacity 
were according to [13]. 
Photoreceptor membranes from rod outer segments (ROS) of 
bovine retina were prepared essentially as described [14] except 
that no thiol reagent was used at any stage of disk membrane 
preparation. The amount of rhodopsin in each preparation was 
determined spectrophotometrically and the spectral criteria of 
purity (A~se~/A5~~) were found to be about 1.8-2.0. 
For reduction of rhodopsin, membranes were solubilized in 
100 mM Tris-HCl, pH 8.6, containing 3 mM EDTA.Nar, 4% 
SDS, 20-fold excess of DTT per mol of cysteine and the 
resulting solution was incubated at 20°C for 12 h. Unreacted 
DTT was removed on a Bio-Gel P-2 column (1.5 x 45 cm) 
equilibrated in 100 mM sodium acetate, pH 4.0, with 3 mM 
EDTA.Na2 and 1% SDS. 
For coupling of rhodopsin to the activated carrier, if no prior 
reduction was required, photoreceptor membranes were 
solubilized in 100 mM sodium acetate, pH 4.0, containing 
3 mM EDTA.Naa and 4% SDS and incubated for 2 h. In the 
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case of the reduced rhodopsin, it was necessary to carry out im- 
mobilization immediately following reduction and passage 
through the Bio-Gel P-2 column. For this purpose the protein 
fraction from the column was directly collected into a reaction 
vial. Dried activated carrier was added to each preparation 
(250 nmol of protein per 1 g of carrier) and the resulting slurry 
was gently rotated for 12 h. 
After immobilization the lipids, detergent and noncovalently 
bound protein were removed by washing the carrier sequentially 
with 10 vols, each 100 mM, sodium acetate, pH 4.0; 4% 
SDS : 50% methanol; 100% methanol; chloroform/methanol 
(2: 1, v/v) and 99.7% formic acid. The conjugate was 
thoroughly washed with water and methanol, then dried. 
solvents; cleavage of the conjugate with CNBr in 
70% formic acid; extraction of free peptides into 
80% formic acid; release of bound peptides by 
treatment with ,&mercaptoethanol and subsequent 
80% formic acid extraction. Thus already at this 
stage peptides were efficiently separated according 
to their cysteine content that provides further 
facile fractionation of each fraction on Bio-Gel 
P-30 and HPLC, if necessary. 
The amount of the immobilized protein was determined by 
the amino acid analysis. A lo-fold excess of 5.7 N HCl was add- 
ed to the conjugate, the ampoule was then evacuated, sealed 
and incubated at 105°C for 24 h. After hydrolysis, the carrier 
was washed with a 5-fold excess of 5.7 N HCl and the soluble 
extract chromatographed on a Durrum D-500 amino acid 
analyzer (Durrum, USA). 
The CNBr cleavage was performed as follows: the immobil- 
ized protein was washed several times with 80% formic acid. 
After the last washing 2-4 vols of 75% formic acid were added 
to the conjugate. Solid cyanogen bromide was added in a 
500-fold excess per mol of methionine, and the reaction was 
carried out at 20°C for 20 h in the dark. The conjugate was 
washed with 10 vols of formic acid, water and methanol, and 
then dried. 
Peptides were detached from the glass by incubation in 
50 mM Tris-HCI, pH 8.6, containing 3 mM EDTA .Naz and a 
20-fold excess of DTT or fl-mercaptoethanol per mol of cysteine 
for 2 h at 20°C. The peptides oluble in the buffer solution were 
combined with those soluble in formic acid and then subjected 
to gel filtration on Bio-Gel P-2 in 80% formic acid. 
However, we found that depending on whether 
the solubilized rhodopsin was subjected to p- 
mercaptoethanol treatment before coupling to the 
support or not, the C-terminal peptide Val-Thr- 
Thr-Leu-Cys-Cys-Gly-Lys-Asn-Pro-Leu-Gly-Asp- 
Asp-Glu-Ala-Ser-Thr-Thr-Val-Ser-Lys-Thr-Glu- 
Thr-Ser-Gin-Val-Ala-Pro-Ala was covalently 
bound or remained in the supernatant, respective- 
ly. Moreover, this peptide found in the superna- 
tant can be easily coupled to the carrier after 
,&mercaptoethanol treatment. For the simplicity of 
further discussion the C-terminal peptides derived 
from CNBr cleavage of rhodopsin coupled to the 
carrier with and without ,&mercaptoethanol treat- 
ment are designated ‘C-r’ and ‘C-n.r’, respectively. 
The peptides were separated on a 1.5 x 100 cm Bio-Gel P-30 
column equilibrated with 80010 formic acid. For HPLC of pep- 
tides the instrument used was an Altex 322 system (Altex, USA) 
with a flow cell spectrophotometer. The effluent was monitored 
at 206 nm. The samples were injected in 80% formic acid. 
The covalently bound fatty acids were released from the 
purified C-terminal CNBr peptide (80 nmol) in 1.0 N KOH for 
12 h at 37°C. The reaction mixture was acidified with HCI and 
fatty acids were extracted several times with hexane. The ex- 
tracts were dried under a stream of Nz at 60°C and subjected 
to methanolysis at 80°C for 4 h using HCI in methanol. Fatty 
acid methyl esters were separated and quantified on a Chrom-5 
gas chromatograph with a flame ionization detector (FID). The 
samples were also analyzed by mass spectrometry. 
3. RESULTS AND DISCUSSION 
The unusual behavior of this peptide led to alter- 
native suggestions: either cysteines 322 and 323 
form an intramolecular disulfide bond or they are 
modified with some fi-mercaptoethanol-sensitive 
group. If we imply that the cysteine residues 322 
and 323 in C-n.r, corresponding to residues 5 and 
6, form a disulfide bond, the Edman degradation 
using hot and cold phenylisothiocyanate (PITC) at 
these steps, respectively, would show the ap- 
pearance of radioactivity at the sixth step, the 
previous one being nonradioactive and blank. 
Such analysis revealed not only the absence of 
radioactivity at the sixth step but also the complete 
blocking of the sequence beginning from the fifth 
one. On the contrary, the sequence of ‘C-r’ in- 
cluding the two cysteine residues either with free or 
iodo-[‘4C]acetamide modified groups is easily 
determined. 
Covalent coupling, of rhodopsin to the carrier It should be noted that unlike C-r or C-r 
(CPG-thiol) through the thiol-disulfide exchange modified with iodo-[14C]acetamide, C-n.r is ir- 
reaction proved to be extremely useful both for ex- reversibly absorbed on a reverse-phase HPLC col- 
haustive cleavage and facile separation of umn and cannot be eluted either with CH30H or 
hydrophobic peptides [13]. In brief, the essence of CH$N at concentrations as high as 90%. That 
this approach included: coupling of rhodopsin was unexpected since even the more hydrophobic 
solubilized in SDS to the carrier; removal of peptides of rhodopsin including those with free 
detergent and lipids by washing with organic thiol groups can be readily recovered from HPLC 
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columns with high yields. Oxidation with perfor- 
mic acid or reduction with ,&mercaptoethanol 
drastically changes the properties of C-n.r and 
results in its high recovery from the HPLC 
column. 
Data presented, on the one hand, exclude the 
possibility of a disulfide bond between the two ad- 
jacent (322-323) cysteine residues in rhodopsin, 
and, on the other, indicate that these residues are 
modified with some groups conferring on the pep- 
tide unusually high hydrophobic features. 
Highly purified samples of bovine rhodopsin 
were shown to contain 1 or 2 mol covalently bound 
palmitates per mol protein [lo]. Incorporation of 
[3H]palmitates was demonstrated using both the 
whole retina or crude rod outer segments (ROS). 
The covalent nature of palmitate attachment was 
proven on the basis of stability of the lipoprotein 
complex in detergent solutions and organic solvent 
commonly used for extraction of lipids from mem- 
brane proteins. 
Furthermore, taking into consideration the 
lability of the complex toward reducing agents, 
hydroxylamine and mild alkaline treatment, it was 
suggested that the fatty acid is bound to rhodopsin 
via thioester linkage [12]. The results of these 
studies taken together with our data on the C- 
terminal fragment of rhodopsin imply that the two 
adjacent cysteines in this peptide are most 
probably acylated with palmitates. 
In order to demonstrate that C-terminal frag- 
ment contains covalently bound fatty acids, 
peptide-bound lipids were released from 80 nM C- 
n.r by alkali hydrolysis and subsequently subjected 
to acid methanolysis. The exact quantity of 
palmitic acid was determined using the GC method 
with the marganic acid methyl ester (Cl7 : 0) as an 
internal standard. The initial quantity of the stan- 
dard was 50 mg. After transesterification with 
HWCH30H and extraction with hexane the sam- 
ple was analyzed in described conditions (see 
fig.1). The coefficient for palmitic acid equal to 
0.94 was calculated by the triangular method. The 
total quantity of C16:O in the initial sample was 
found to be 47 mg, which corresponds exactly to 
2 mol palmitic acid per mol of the C-terminal 
CNBr peptide. 
Palmitic acid was further identified by mass 
spectrometry (fig. 1). The mass spectra for palmitic 
acid methyl ester released from the C-terminal pep- 
17 0 
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I; 
6- 
5 10 15 Retention time, 
min 
Fig.1. Covalently bound fatty acids in bovine rhodopsin. (A) 
The separation of fatty acid methyl esters on a gas 
chromatograph; column: 5‘70 silar 1OC on chromosorb W-AW 
(100-120 mesh), 2500 x 4 mm; GC conditions: 15O”C, initial 
t; t inj, 200°C; t det, 245°C. (B) Mass spectrum of 16 carbon 
methyl ester (17:0 - internal standard). 
tide matched exactly that of the standard sample of 
Cl6 : 0 as far as the molecular ion and other 
characteristic ions are concerned [ 141. 
In the light of these results the unusual proper- 
ties of C-n.r and the cease of the sequence at the 
fifth step may now be easily explained. First, two 
fatty acid molecules confer hydrophobic properties 
on this peptide preventing its elution from a HPLC 
column. Second, as mentioned above, the sequen- 
tial degradation of C-n.r ceased at the fifth step 
corresponding exactly to the first cysteine residue 
in the peptide. Interaction of the thioester carbonyl 
function with a newly exposed amino group of cys- 
teine 322 may result in water elimination with 
subsequent cyclization [15] and blocking of the se- 
quence. 
The physiological importance of rhodopsin 
acylation is still unclear. The absorption of a 
photon of light by rhodopsin results in the cis to 
trans isomerization of retinal. This configurational 
change in the chromophore is expressed in a series 
of conformational changes in the protein. Ac- 
cording to a number of biochemical data the most 
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obvious of these changes occur in the C-terminal 
cytoplasmic domain of rhodopsin. It is conceivable 
that the structural changes in this fragment expose 
the binding sites for transducin either on its own or 
on other cytoplasmic regions. The conformational 
alterations followed by light absorption not only 
provide transducin binding sites but also drive 
phosphorylation of up to nine threonine and serine 
residues in the C-terminal fragment by opsin 
kinase. Then phosphorylation induces the subse- 
quent binding of a protein known as ‘48 kDa’ pro- 
tein leading to rhodopsin inactivation. Thus the 
C-terminal cytoplasmic fragment of photoexcited 
rhodopsin acquires a substrate status for at least 
three soluble proteins [16]. 
Increased sensitivity of this fragment to pro- 
teolysis after illumination provides important ad- 
ditional evidence of its conformational change 
upon photoactivation of rhodopsin. In fact, the 
accessibility of 12 C-terminal amino acids to ther- 
molysin, although reversible in a time-dependent 
manner is significantly increased at the stage of 
metharhodopsin II [17]. Interestingly enough, this 
cleavage always precedes the exposure of addi- 
tional protease sensitive sites on the second and 
third cytoplasmic loops connecting the 3-4 and 
5-6 transmembrane segments. Furthermore the C- 
terminal peptide of about 40 amino acid residues is 
shown in all proposed models [16] as being ex- 
posed (fig.2). It contains a number of sites com- 
monly sensitive to proteases of high specificity, 
such as trypsin, S. aureus V8 protease, however, 
neither these nor the protease of such a wide 
specificity as papain result in exhaustive cleavage 
of this fragment. Limited cleavage at the peptide 
bond Leu-Cys-321-322 by papain is achieved 
when using an enzyme substrate ratio as high as 
1: 10 and for at least 5-6 h at room temperature. 
On the contrary, exhaustive cleavage of this frag- 
ment is observed on apomembranes obtained by 
treatment of rhodopsin with hydroxylamine in the 
light [18]. 
It is tempting to suggest hat fatty acylation of 
rhodopsin may promote a proper functional an- 
chorage of the C-terminal fragment to the 
photoreceptor membrane thus preventing it from 
non-physiological exposure and protease action. 
Recent sequence analysis demonstrated that the 
C-terminal fragments of various rhodopsins con- 
tain from one to three cysteines [16]. Careful 
4 
Fig.2. Sixth and seventh transmembrane rods and cytoplasmic 
fragment of the rhodopsin molecule. Lys residue responsible 
for retinal binding is in segment VII. Residues Cys-322 and 
Cys-323 are palmitylated. 
analysis of possible fatty acid acylation of both 
vertebrate and invertebrate proteins may further 
clarify the functional importance of this modifica- 
tion. In any case bovine rhodopsin palmitylation 
raises questions related to cleavage and reforma- 
tion of the thioester bond and involvement of some 
well known or still unknown proteins of ROS in 
this process. 
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